Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration
Status:
Terminated
Trial end date:
2021-08-26
Target enrollment:
Participant gender:
Summary
Subjects with Fuchs dystrophy will be randomized to use either netarsudil or placebo eye
drops to determine if the use of netarsudil accelerates migration of host peripheral corneal
endothelial cells to restore the central endothelial cell layer.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Cornea Research Foundation of America Price Vision Group